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Background: Schizophrenia is a severe mental disorder affecting .21 million people 
worldwide. Some genetic studies reported that single nucleotide polymorphism (SNP) involving 
variant rs1344706 from the ZNF804A gene in human beings is associated with the risk of schizo-
phrenia in several populations. Similar results tend to conflict with other reports in literature, 
indicating that no true significant association exists between rs1344706 and schizophrenia. We 
seek to determine the level of association of this SNP with schizophrenia in the Asian population 
using more recent genome-wide association study (GWAS) datasets.
Methods: Applying a computational approach with inclusion of more recent GWAS datasets, 
we conducted a meta-analysis to examine the level of association of SNP rs1344706 and the risk of 
schizophrenia disorder among the Asian population constituting Chinese, Indonesians, Japanese, 
Kazakhs and Singaporeans. For a total of 21 genetic studies, including a total of 28,842 cases 
and 35,630 controls, regression analysis, publication bias, Cochran’s Q and I2 tests were per-
formed. The DerSimonian and Laird random-effects model was used to assess the association 
of the genetic variant to schizophrenia. Leave-one-out sensitivity analysis was also conducted 
to determine the influence of each study on the final outcome of the association study.
Results: Our summarized analysis for Asian population revealed a pooled odds ratio of 1.06, 
95% confidence interval of 1.01–1.11 and two-tailed P-value of 0.0228. Our test for heterogene-
ity showed the presence of large heterogeneity (I2=53.44%, P =0.00207) and Egger’s regression 
test (P =0.8763) and Begg’s test (P =0.8347), indicating no presence of publication bias among 
our selected studies. In our sensitivity analysis, 10 different studies comprising of ~50% of the 
entire study had an impact on our final results as each leave-one-out test became insignificant. 
Our result suggests that genetic variant rs1344706 might be associated with the development 
of schizophrenia in Asians.
Keywords: meta-analysis, schizophrenia, single nucleotide polymorphism, heterogeneity, 
genetic variant
Introduction
Schizophrenia is a severe mental disorder, characterized by profound disruptions in 
thinking, thereby affecting language, perception and sense of self.1 It has been identified 
as one of the world’s major health disorders. It is one of the disorders that has had a 
significant effect on the world population, affecting .21 million people. This disorder 
is mainly common among young people between ages of 15 and 35 years.
The manner of development of schizophrenia may be dependent on our different 
genetic makeup.2 The genetic differences of individuals from different ethnic groups 
may determine who is susceptible to schizophrenia or not, and the identification of 
these variations can be helpful in delivering personalized treatments to patients.3 
Personalized treatments also involve the prevention and delivery of treatments to 
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patients, based on their genetic makeup and environment.4 
Genome-wide association study (GWAS) has proved to be 
a useful technique in associating variations in our genome 
to specific diseases using statistical procedures.
In the event of identifying a significant association 
between the single nucleotide polymorphism (SNP) and a 
disease phenotype, such an association is validated by the 
replication of the statistical procedures on another sample 
or a smaller subset of the initial sample.5 However, when 
different authors undertake different GWAS experiments, 
they sometimes may obtain conflicting reports using the same 
experimental conditions; conflicts in reports occur when dif-
ferent authors are not able to replicate their results under the 
same experimental conditions, all things being equal.
Meta-analysis is a technique used to resolve conflicts 
and discrepancies in GWAS reports. An added advantage of 
meta-analysis is that it reduces the stress experienced when 
handling the full genotype data for several GWAS analyses; 
only the result files are required in a meta-analysis.3,6 Another 
advantage of meta-analysis in GWAS is the elimination of the 
dangers of passing on confidential information and genotype 
data for the cases, as they are not useful in the computation.
Much research has been undertaken to find variations 
in human DNA that make susceptibility to schizophrenia 
possible. In the study by O’Donovan et al,7 SNP rs1344706 
was identified as a risk factor to the pathogenesis of schizo-
phrenia in European populations. Chen et al8 also found a 
significant association of SNP rs1344706 with schizophrenia 
in Chinese population, indicating stronger association of 
SNP rs1344706 with higher intelligent quotient (IQ) scores 
in schizophrenia patients. However, Li et al9 did a candidate 
gene study in two different groups and found no significant 
association between SNP rs1344706 and schizophrenia in 
Chinese population. In their analysis, SNP rs359895 was 
found to have a strong association with schizophrenia in the 
Chinese population.
Li et al10 did a meta-analysis of 10 Chinese samples 
and two Japanese samples and found no association with 
SNP rs1344706. In addition, performing further analysis, 
they detected that the SNP rs359895 has an association 
with schizophrenia in the Chinese population. Zhu et al11 
performed a meta-analysis containing 13 Chinese samples, 
10 Caucasian samples and two samples from other popula-
tions. Stratified and combined analysis in the three different 
groups showed association of SNP rs1344706 with schizo-
phrenia. The abovementioned narrative indicates the presence 
of inconsistent results in the association of SNP rs1344706 
in the Han Chinese population; hence, there is the need of 
meta-analysis. In this meta-analysis, a total of 21 genetic 
studies were used, with 13 of these studies reporting no 
association between the SNP and schizophrenia,7,9,12–19 while 
eight studies reported that there was an association.8,20–26
Methods
Search for relevant studies from 2006 to 2016 was conducted 
using online databases which included Web of Science, 
PubMed and Science Direct. Keywords applied in the search 
process are listed as “Schizophrenia”, “Chinese”, “associa-
tion”, “rs1344706” and “ZNF804A” between 2006 and 2016. 
There were previous meta-analysis studies that were obtained 
in our initial search, and their bibliographies were searched 
to obtain more results.
The selection criteria for this meta-analysis included the 
following: study must be case/control design, study must 
have at least 100 cases and controls, study must genotype 
the polymorphism rs1344706 and, finally, the disease being 
investigated must be schizophrenia. Table 1 shows our initial 
results.
Description and preprocessing 
of input data
Table 2 shows the selected studies that were used by the 
packages for the meta-analysis. The columns include the 
author name and the year of publication, the number of cases 
multiplied by 2 (ntrt), the number of controls multiplied 
by 2 (nctrl), the number of cases that have the risk allele 
(events in cases, ptrt), the number of controls that have the 
risk allele (events in controls, pctrl), the frequency of the risk 
allele (A or T) in affected persons (FA), the frequency of the 
risk allele in unaffected persons (FU) and the mean ages of 
cases and controls, and the inference column indicates if the 
authors’ results show association. The values in ntrt and nctrl 
columns have been scaled by two compared to that found 
in Table 1. This is done because an SNP has typically two 
alleles; therefore, this is accounted for by multiplying the 
total number of individuals for a study by 2. Table 2 shows 
the result of preprocessed input data used by our program.
regression analysis between mean ages 
and effect sizes
We checked if the mean ages could have influenced the 
values of the odds ratio (OR). The mean age for each study 
is shown in Table 1. We could not obtain the mean ages 
for seven different studies, so we excluded them from our 
analysis. Our results shown in Table 3 indicate that the OR 
is not greatly influenced by the mean ages.
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Table 1 selected studies for our meta-analysis
Study, year Cases/
controls
Area Country FA/FU Mean age (years) 
cases/controls
Association
chen et al,8 2012 570/448 shandong china 0.564/0.508 28.2/23 Yes
li et al,9 2011 488/694 Yuxi china 0.506/0.503 30.5/37.1 No
li et al,9 2011 403/604 Kunming china 0.5/0.516 36.3/36.6 No
li et al,12 2012 885/976 singapore singapore 0.52/0.506 49/46.1 No
O’Donovan et al,7 2008 996/1,015 shanghai china 0.53/0.514 38.8/30 Yes
shi et al,13 2011 1,224/2,788 shanghai and anhui china 0.517/0.503 36.2/60.9 No
shi et al,13 2011 1,510/1,546 Beijing and shandong china 0.48/0.501 36.9/30.8 No
shi et al,13 2011 883/2,010 guangdong and guangxi china 0.494/0.506 36.3/56.1 No
steinberg et al,14 2011 439/446 sichuan china 0.533/0.546 Na/Na No
Xiao et al,20 2011 496/448 Xinxiang china 0.601/0.536 28.6/29.2 Yes
Zhang et al,21 2011 566/574 Xi’an china 0.527/0.457 33.9/29.2 Yes
hashimoto et al,22 2010 113/184 Nr Japan 0.588/0.53 Na/Na Yes
liou et al,15 2012 522/793 Taiwan Taiwan 0.512/0.501 44.1/67.4 No
Kuswanto et al,24 2012 111/67 Nr china 0.527/0.56 Na/Na Yes
schwab et al,23 2013 1,067/1,111 Jakarta indonesia 0.525/0.489 33.4/31.9 Yes
Yang et al,16 2013 1,024/975 Xinxiang china 0.538/0.51 Na/Na No
lan et al,25 2013 250/201 Nr china 0.48/0.557 Na/Na Yes
saito et al,17 2014 1,032/993 Nr Japan 0.438/0.414 Na/Na No
stepanov et al,18 2015 112/190 Nr Kazakhstan 0.495/0.5 16.8/31.6 No
Zhang et al,26 2015 746/762 shanghai china 0.535/0.512 Na/Na Yes
Wang et al,19 2016 1,284/990 Jiangsu china 0.512/0.503 45.79/44.86 No
Note: Fa – the frequency of the risk allele in affected persons (a or T), FU – the frequency of the risk allele in unaffected persons.
Abbreviations: Nr, not reported; Na, not applicable.
Table 2 Preprocessed input data
Study ntrt nctrl ptrt pctrl FA/FU Mean age (years) 
cases/controls
chen et al8 1,140 896 643 455 0.564/0.508 28.2/23
li et al9 (Y) 976 1,388 494 698 0.506/0.503 30.5/37.1
li et al9 (K) 806 1,208 403 623 0.5/0.516 36.3/36.6
li et al12 1,770 1,952 920 988 0.52/0.506 49/46.1
O’Donovan et al7 1,992 2,030 1,056 1,043 0.53/0.514 38.8/30
shi et al13 (1) 2,448 5,576 1,266 2,805 0.517/0.503 36.2/60.9
shi et al13 (2) 3,020 3,092 1,450 1,549 0.48/0.501 36.9/30.8
shi et al13 (3) 1,766 4,020 872 2,034 0.494/0.506 36.3/56.1
steinberg et al14 878 892 468 487 0.533/0.546 Na/Na
Xiao et al20 992 896 596 480 0.601/0.536 28.6/29.2
Zhang et al21 1,132 1,148 597 525 0.527/0.457 33.9/29.2
hashimoto et al22 226 368 133 195 0.588/0.53 Na/Na
liou et al15 1,044 1,586 535 795 0.512/0.501 44.1/67.4
Kuswanto et al24 222 134 117 75 0.527/0.56 Na/Na
schwab et al23 2,134 2,222 1,120 1,087 0.525/0.489 33.4/31.9
Yang et al16 2,048 1,950 1,102 995 0.538/0.51 Na/Na
lan et al25 500 402 240 224 0.48/0.557 Na/Na
saito et al17 2,064 1,986 904 822 0.438/0.414 Na/Na
stepanov et al18 224 380 111 190 0.495/0.5 16.8/31.6
Zhang et al26 1,492 1,524 798 780 0.535/0.512 Na/Na
Wang et al19 2,568 1,980 1,315 996 0.512/0.503 45.79/44.86
Notes: ntrt, the number of cases multiplied by 2; nctrl, the number of controls multiplied by 2; ptrt, the number of cases that have the risk allele (events in cases); pctrl, 
the number of controls that have the risk allele (events in controls); Fa, the frequency of the risk allele in affected persons (a or T); FU, the frequency of the risk allele in 
unaffected persons, and the mean ages in cases and controls. (1), shanghai and anhui; (2), Beijing and shandong; (3), guangdong and guangxi.
Abbreviations: Na, not applicable; (Y), Yuxi; (K), Kunming.





From our coefficient of determination (R2), ~3.9% of the 
OR can be determined by the mean ages for cases and 16% for 
the controls. In addition, the P-values obtained (P=0.4987) 
for cases and (P=0.1524) for controls are not statistically 
significant; hence, the mean ages are not influencing the OR 
results in any way.
assessing publication bias
Meta-analysis is a useful technique for finding a true effect 
size among a distribution of effect sizes. However, the 
results of a meta-analysis are only as valid as the results of 
the studies included in it. If studies are selected for inclu-
sion into the meta-analysis with bias, the validity of such 
analysis will be greatly affected. Publication bias is said to 
occur when favorable findings are reported by the author 
rather than unfavorable ones.27,28 In Figure 1, we show the 
funnel plot for our meta-analysis. The eyeball test shows that 
the distribution of studies is symmetrical, ie, studies are not 
coagulated into one quadrant of the funnel.
The Egger’s regression test (P-value =0.8763) and Begg’s 
test (P-value =0.8347),29 which are other tools that can also 
be used to assess publication bias, showed no presence of 
publication bias.
assessing degree of heterogeneity
Our Cochran’s Q and I2 tests for heterogeneity showed the 
presence of large heterogeneity. This is very feasible since 
most studies were not conducted by the same author, random 
errors that could occur as a result of mistakes made by the 
experimenter and actual between variance could be the causes 
of the amount of heterogeneity observed.
The null hypothesis says that “all studies share a common 
effect size”, and from our P-value, we reject this hypothesis. 
The Cochran’s Q and I2 test results shown in Table 4 confirm 
the fact that all studies do not share a common effect size.
computation of Dersimonian and laird 
random-effects model
This meta-analysis used the allelic model of comparison to 
inspect the association of SNP rs1344706 with schizophrenia in 
Asian populations, which included Chinese, Kazakhs, Singa-
poreans, Indonesians and Japanese. Random-effects model 
was used in the computation of the meta-analysis, since hetero-
geneity of 54% was obtained. From our results, we observed 
that individuals who are carriers of the A or T allele of the 
SNP rs1344706 have a 6% increased risk of susceptibility to 
schizophrenia in Asian population. Table 5 shows our statistical 
results; Figure 2 shows the forest plot for included studies.
sensitivity analysis
This analysis is performed to check if any single study 
included in the meta-analysis might have a significant effect 
on the final results. To achieve this test, data for each study 
is removed such that the heterogeneity, publication bias, 
and meta-analysis are then recalculated for the remaining 
studies, so that the impact of the removed data on the overall 
study can be ascertained. Table 6 shows the results of our 
sensitivity analysis. The P-value and OR were not significant 
for 10 studies of the leave-one-out sensitivity analysis. This 
indicates that these studies have a significant impact on the 
results of the final meta-analysis.
Table 3 statistical results of regression analysis between Or and mean age in cases and controls
Regression analysis Results in cases Results in controls
R2 0.03897 0.1629
adjusted R2 -0.04112 0.09315
F-statistic 0.4866 2.335
P-value 0.4987 0.1524
suggested regression equation Or =1.192-0.0032*mean_age Or =1.235+0.0038*mean_age
Abbreviation: Or, odds ratio.
Figure 1 Funnel plot showing publication bias for meta-analysis of rs1344706 
(standard error vs log Or).
Abbreviation: Or, odds ratio.
Table 4 results of heterogeneity tests (cochran’s Q and I2 tests)
Heterogeneity test Results
cochran’s Q 43
Degrees of freedom 20
I2 test 53.44% (large heterogeneity)
P-value 0.00207
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Discussion
SNP rs1344706, an intronic SNP in ZNF804A, has been 
identified with an increased risk of schizophrenia in several 
human populations. However in the Asian human population, 
the results have been inconsistent. Steinberg et al14 undertook 
GWAS and follow-up analysis for several populations and 
found no significant association between the SNP rs1344706 
and schizophrenia in the Chinese population. Li et al9 also 
did a candidate gene study in two different groups and also 
found no significant association between SNP rs1344706 and 
schizophrenia in the Chinese population. In their analysis, 
SNP rs359895 also located in the same ZNF804A gene was 
found to have a strong association with schizophrenia in the 
Chinese population. However, Chen et al,8 investigating the 
association of SNP rs1344706, found that it had a significant 
association with schizophrenia in the Chinese population; the 
interaction of the association with different levels of patient 
IQ scores was checked, and it was observed that there was a 
stronger significant association of SNP rs1344706 with higher 
patient IQ scores. Meta-analysis has been a proven tool useful 
for resolving conflict reports and to increase power in a study. 
Meta analysis tries to estimate the consistency of effect size 
across the group of studies, and based on this consistency, it 
tries to estimate a summary effect size.30 Meta-analysis was 
used to find the true effect size of SNP rs1344706 against the 
risk of schizophrenia.
A total of 21 genetic studies were included in this meta 
analysis, of which 13 were in support of the null hypothesis, 
while the other eight studies found a positive association. 
Looking at the reports of each study that reported no asso-
ciation, reasons for lack of association could be extracted. 
A common reason for non-association observed from several 
Figure 2 Forest plot showing meta-analysis for the association between sNP rs1344706 and schizophrenia.
Abbreviations: OR, odds ratio; CI, confidence interval; SNP, single nucleotide polymorphism; (Y), Yuxi; (K), Kunming.
τ
Table 5 random effect summary results






P-value (two tailed) 0.0228
Abbreviations: OR, odds ratio; CI, confidence interval.





Table 6 leave-one-out sensitivity analysis
Study removed Eggers’s pval Begg’s pval I2 het_ pval meta_pval OR 95% CI
lb ub
chen et al8 0.8287 0.6771 51.4 0.0043 0.0477 1.051 1 1.105
li et al9 (Y) 0.883 1 55.52 0.0014 0.0239 1.061 1.01 1.116
li et al9 (K) 0.9101 1 53.97 0.0022 0.015 1.064 1.01 1.116
li et al12 0.8762 0.9745 55.77 0.0013 0.0306 1.059 1.01 1.116
O’Donovan et al7 0.8797 0.7732 55.73 0.0013 0.0343 1.058 1 1.116
shi et al13 (1) 0.8726 0.8728 55.76 0.0013 0.0359 1.059 1 1.116
shi et al13 (2) 0.7348 0.5006 45.82 0.0137 0.0053 1.07 1.02 1.127
shi et al13 (3) 0.8074 0.5006 51.9 0.0038 0.0123 1.066 1.01 1.116
steinberg et al14 0.9132 0.9235 54.44 0.0019 0.0166 1.063 1.01 1.116
Xiao et al20 0.8066 0.6308 49.46 0.0067 0.0485 1.049 1 1.105
Zhang et al21 0.8357 0.7246 46.21 0.0128 0.0512 1.047 1 1.094
hashimoto et al22 0.7092 0.5424 54.52 0.0019 0.0335 1.055 1 1.105
liou et al15 0.877 0.9745 55.76 0.0013 0.0286 1.059 1.01 1.116
Kuswanto et al24 0.9571 0.8728 55.03 0.0016 0.0194 1.061 1.01 1.116
schwab et al23 0.9178 0.9235 53.21 0.0027 0.0482 1.053 1 1.105
Yang et al16 0.8968 0.8728 54.81 0.0017 0.0425 1.055 1 1.116
lan et al25 0.8714 0.8227 46.59 0.0119 0.005 1.068 1.02 1.116
saito et al17 0.8916 0.8728 55.2 0.0016 0.0402 1.056 1 1.116
stepanov et al18 0.9268 1 55.58 0.0014 0.0225 1.06 1.01 1.116
Zhang et al26 0.8787 0.8728 55.45 0.0014 0.0369 1.056 1 1.116
Wang et al19 0.8654 0.6771 55.68 0.0013 0.0291 1.06 1.01 1.116
Notes: Sensitivity analysis used to monitor the influence and impact of each study on the entire population. This table shows the publication bias P-value (Begg’s), the 
heterogeneity I2 and het_pval, the overall P-value (meta-pval) and the overall Or with a 95% ci.
Abbreviations: pval, P-value; OR, odds ratio; CI, confidence interval; lb, lower bound; ub, upper bound; (Y), Yuxi; (K), Kunming.
studies included the risk allele frequencies of the SNP in the 
comparison groups. Li et al9 argued that studies with allele 
frequencies that differed to an extent from the frequency of 
the allele on HapMap31 and from the frequency reported in 
their studies were likely to have an opposite association. In 
their work, the T allele frequency of rs1344706 in the com-
parison (case/control) samples was 0.509, which is similar 
to the frequencies reported by O’Donovan et al7 (0.514) 
and Steinberg et al14 (0.546) as well as the frequency in 
the Han Chinese population from the HapMap31 database 
(0.524). It is quite different, however, from the frequency 
reported by Zhang et al21 (0.457) or Chen et al8 (0.564). We 
performed simple logistic regression to determine if the risk 
allele frequency of each study might affect the significance 
of a study result. We obtained a P-value of 0.0596 (~0.06), 
indicating that the allele frequencies might not be directly 
influencing the statistical association for each study. Other 
factors that might affect the association of a genetic study 
include the use of covariates in the analysis, subgroup 
analysis performed, disease model or type of statistical 
analysis used, type of multiple testing corrections used, 
etc. On the other hand, uncontrolled bias can also affect 
statistical association. Another strong reason given for the 
absence of association includes genetic architecture exist-
ing between the Asian and Caucasians. Li et al12 stated that 
the SNP might be inherited together with a functional change 
in the gene in Europeans, which is not the case in Asians. The 
linkage disequilibrium map of the genomic region showed 
a sharp change between the Caucasians and Asians. Wang 
et al19 stated that demographic differences can be the cause of 
inconsistencies in results. China is a country known to have 
complex demography and ethinic diversity, which might 
cause people from different regions to be born with different 
genetic traits. Other reasons include genetic heterogeneity, 
where different alleles are contributing to the pathogenesis 
of the genetic disorder; environmental exposure; the local 
culture and difference of schizophrenia subtypes in the 
subjects included.
The results of this meta-analysis indicated that a statisti-
cal significance exists between the phenotype of interest 
and genotype; several tests were also performed to ensure 
the validity of the meta-analysis. Regression analysis was 
performed between the OR and mean ages to check for rela-
tionships; publication bias was performed to remove false 
results, and degree of heterogeneity was checked to detect the 
variance among the selected studies. This meta-analysis used 
the allelic model of comparison to inspect the association, and 
we observed that individuals who are carriers of the A or T 
allele of the SNP rs1344706 have a 6% increased risk of 
susceptibility to schizophrenia in the Chinese population.
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From the entire population study investigated, the output 
generated from the meta-analysis portends that there is a sig-
nificant association between the considered SNP rs1344706 
and the prevalence of the schizophrenia disease. However, 
the systematic investigation of the Chinese population as a 
subgroup that accounted for 16 studies out a total of 21 stud-
ies investigated reveals that there is no significant association 
between the SNP and the disease condition. The implication 
may be that the effect of the SNP toward the prevalence of 
schizophrenia in Chinese is predominantly less compared to 
other Asian populations considered in this work. Considering 
the implication of our discovery, the significance of improv-
ing and increasing investments in this field of research is 
recommended by virtue of the fact that the SNP rs1344706 is 
indicted in the disease risk condition of schizophrenia. This 
will also help to address the issues of management therapy 
and treatment discovery for ameliorating the condition of 
patients plagued with schizophrenia.
Conclusion
Meta-analysis study appears to be a continuous process as 
fresh genotyping datasets from new GWAS studies for a 
specific population are made available. To this end, meta-
analysis tests are performed to revalidate existing hypotheses 
using newer GWAS datasets. The association of this SNP 
has been inspected by four previous meta-analyses,10,11,32,33 
with the first study consisting of 12 studies from the Chinese 
population and stating no association and the second study 
consisting of 13 studies from the Asian population and 
stating the presence of association. The third meta-analysis 
consisted of 30 studies, which included Asians, Caucasians 
and Americans. The results presented stated the presence of 
association between the SNP and schizophrenia disorder. 
The last meta-analysis consisted of 18 studies from Asian 
population, and the results showed statistical significance. 
However, we included more datasets in our work for Asian 
population. Our work also provided a unique perspective 
view to a combination of population studies from various 
authors with GWAS experimental data. We also applied 
R programming, which is a powerful statistical programming 
tool in our analysis. In addition, Li et al10 had a different 
result from our analysis, while our result seems to agree with 
references.11,32,33 It is important to note that due to our interest 
in understanding the controversy surrounding the associa-
tion of schizophrenia with SNP rs1344706 among Chinese, 
Japanese, Singaporean, Indonesian, and Kazakh holistically, 
it was not in our interest to include populations such as the 
Caucasian and American as in the study by Sun et al.32
Our result shows that individuals who are carriers 
of A and T allele of SNP rs1344706 have 6% increased 
risk of schizophrenia susceptibility among the combined 
population of Chinese, Japanese, Singaporean, Indone-
sian and Kazakh. While desiring to investigate the effect 
of each study on the overall result of the meta-analysis, 
our sensitivity analysis reveals that 48% of the studies 
used in the analysis had undue dominance or influence 
on the overall result. This may be due to other unforeseen 
factors in the experimental design since we also took 
account of age and other factors that could bias our results.
The motivation to perform new GWAS studies could 
discover more polymorphisms associated with the disease as 
this disease is multigenic or polymorphic with a higher statisti-
cal significance; this can be boosted by GWASs with a higher 
sample size or usage of latest sequencing technologies.
Schizophrenia is one of the severe brain disorders affect-
ing .21 million people in the world today. Although the 
disorder has a remedy, identifying the areas of the DNA 
responsible for susceptibility to such a disorder can help in 
building more therapeutic remedies for it. SNP rs1344706 has 
been identified as being associated with the susceptibility of 
schizophrenia in several populations; however, in the Asian 
and Chinese populations, there have been several conflicting 
reports. This study thus confirms and validates further the 
claim by the (eight) previous authors/literature of a significant 
association between the genotype and phenotype.
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